Medtronic (MDT) is exploring options to optimize its global manufacturing operations in order to mitigate the impact of US President Donald Trump's tariff plans, Reuters reported Tuesday, citing the company's chief technology officer, Ken Washington.
The medical device maker has been closely monitoring Trump's tariff plans due to its presence in Mexico, which houses Medtronic's third largest manufacturing facility, the report said.
This comes after Trump imposed 25% duties on imports from Mexico and Canada that were to become effective early this month, but have been delayed until March 4 pending negotiations with the two countries.
Washington did not mention whether India was also part of the strategy to refine manufacturing operations, where the company launched its largest research and developmental center outside of the US in 2021, Reuters reported.
The company did not immediately respond to MT Newswires' request for comment on the matter.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。